Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

Opinion & Analysis (TSXV:BTI.H)

    Bioasis Technologies: A Very BIG Year in Review

    Dave Jackson December 18, 2020

    The Revolutionary Co. That’s Breaking Through the Blood Brain Barrier

    Dave Jackson December 2, 2020

    A ‘Barrier’ to Better Health

    Dave Jackson September 30, 2020

    An Emerging Medical Market Play with Great Opportunity

    Stockhouse Editorial July 29, 2020

    Bioasis Engages With the FDA: Here's What It Means

    Streetwise Reports July 6, 2019

    Maya Gold (V.MYA) reports 2014 production and outlook for 2015

    Stockhouse Editorial March 10, 2015

    Haywood snaps up 10,000 BiOasis shares (V.BTI)

    Stockhouse Editorial September 30, 2013